BiotechTube

Carticel (autologous cultured chondrocyte) implantation

ApprovedCompleted
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Articular Cartilage

Conditions

Articular Cartilage

Trial Timeline

Mar 1, 2000 → Nov 1, 2005

NCT ID
NCT00158613

About Carticel (autologous cultured chondrocyte) implantation

Carticel (autologous cultured chondrocyte) implantation is a approved stage product being developed by Vericel for Articular Cartilage. The current trial status is completed. This product is registered under clinical trial identifier NCT00158613. Target conditions include Articular Cartilage.

What happened to similar drugs?

0 of 4 similar drugs in Articular Cartilage were approved

Approved (0) Terminated (0) Active (4)
🔄MRA(Tocilizumab)Chugai PharmaceuticalPhase 3
🔄AbataceptBristol Myers SquibbPhase 3
🔄Certolizumab Pegol (CZP) + Certolizumab Pegol (CZP)UCBPhase 3
🔄autologous cultured chondrocytes on porcine collagen membraneVericelPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00158613ApprovedCompleted
NCT00140634Pre-clinicalCompleted

Competing Products

6 competing products in Articular Cartilage

See all competitors
ProductCompanyStageHype Score
MRA(Tocilizumab)Chugai PharmaceuticalPhase 3
40
AbataceptBristol Myers SquibbPhase 3
40
Certolizumab Pegol (CZP) + Certolizumab Pegol (CZP)UCBPhase 3
40
autologous cultured chondrocytes on porcine collagen membraneVericelPhase 3
34
autologous cultured chondrocytes on porcine collagen membraneVericelPre-clinical
20
Carticel (autologous cultured chondrocyte) implantationVericelPre-clinical
20